Pfizer has welcomed Amit Agarwal into the role of Chief Financial Officer. According to official records filed with the stock exchange, Agarwal’s appointment also includes a significant role as an additional director, holding the position of Executive Director – Finance & Chief Financial Officer. This appointment is effective from February 26, 2024, and is slated for a duration of five years.
Prior to joining Pfizer, Agarwal held a prominent position at Hindustan Unilever Limited (HUL), where he served as the General Manager of Finance, overseeing the finance function for the sales and customer development vertical. Additionally, in his capacity as the Financial Controller for Global Business Services (GBS), he led a comprehensive end-to-end controllership. This role involved collaborating with a diverse team spread across geographies, including India, the UK, the Philippines, and Brazil.
Before his tenure at HUL, Agarwal contributed to Vedanta Resources Limited, where he served as a Financial Planning & Analysis Manager and later as a Factory Commercial Manager. His multifaceted background positions him well to contribute to Pfizer’s financial strategies and objectives in the years to come.
Have you read?
Top 50 global artists list, 2023: These are the most successful living artists in the World.
These Are The Most Popular Songs For The Workplace Productivity.
25 of the world’s oldest billionaires in 2023, ranked.
Ranked: Countries That Produce the Most Carbon Dioxide (CO2), 2023.
Ranked: These Are The Most Desirable Jobs in the World, 2023.
Ranked: U.S. states by the number of billionaires, 2023.
Add CEOWORLD magazine to your Google News feed.
Follow CEOWORLD magazine headlines on: Google News, LinkedIn, Twitter, and Facebook.
Copyright 2024 The CEOWORLD magazine. All rights reserved. This material (and any extract from it) must not be copied, redistributed or placed on any website, without CEOWORLD magazine' prior written consent. For media queries, please contact: info@ceoworld.biz
